aTyr Pharma Stock Forecast

ATYR's stock price has decreased by -90.85% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 9 analysts polled by S&P Global, aTyr Pharma stock has a consensus rating of "Buy" and an average price target of $2.86. The average 1-year stock price forecast is 495.83% higher than the current stock price, while the lowest is $1.00 (+108.33%) and the highest is $7.00 (+1,358.33%).

Price Target: $2.86 (+495.83%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$1.00	$2.86	$3.00	$7.00
Change	+108.33%	+495.83%	+525.00%	+1358.3%

Analyst Ratings

The average analyst rating for aTyr Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	1	1	1	2	2	2
Buy	2	2	2	2	2	2
Hold	7	6	6	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jul 16, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $7	Buy	Maintains	$7	+1,358.33%	Jul 16, 2026
Boris Peaker JonesTrading	JonesTrading	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jul 16, 2026
Ilya Zubkov Freedom Capital Markets	Freedom Capital Markets	Buy Upgrades $1 → $3.5	Buy	Upgrades	$1 → $3.5	+629.17%	May 20, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Reiterates $1	Hold	Reiterates	$1	+108.33%	May 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 190.00K

-100.00%

from 190.00K

Revenue Next Year

n/a

EPS This Year

-0.58

from -0.80

EPS Next Year

-0.63

from -0.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	10.39M	353.00K	235.00K	190.00K	-
Revenue Growth	-	-	-96.60%	-33.43%	-19.15%	-100.00%
Operating Income	-34.02M	-46.40M	-54.92M	-67.91M	-77.63M	-57.01M
Net Income	-33.77M	-45.34M	-50.39M	-64.02M	-74.12M	-54.96M
EPS	-	-	-	-	-0.80	-0.58
Free Cash Flow	-20.32M	-27.93M	-21.18M	-44.36M	-33.80M	-57.00M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.46
Avg	-0.58
Low	-0.76

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-